Skip to main content

A 2-part study of an open-label multiple ascending dose (MAD) safety study, and a dose-finding single-masked comparative safety and preliminary efficacy study of intravitreal EYE103 (Restoret®) in a mixed population of participants with DME and NVAMD

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Eyebiotech Ltd.

Start Date

March 16, 2023

End Date

February 29, 2024
 

Administered By

Ophthalmology

Awarded By

Eyebiotech Ltd.

Start Date

March 16, 2023

End Date

February 29, 2024